Project Details
Description
Title: Inves�ga�ng the Impact of Novel Senescent Microglia in Alzheimer's Disease Pathology
Abstract: Alzheimer's Disease (AD) is a debilita�ng neurodegenera�ve disorder with a cri�cal need for
improved therapeu�c strategies. One controversial component of AD progression is the role of microglia,
the brain's immune cells. Recent research indicates a subpopula�on of these cells exhibi�ng senescence
characteris�cs, raising the ques�on if these senescent microglia might contribute to AD progression
through a senescence-associated secretory phenotype (SASP). Our proposal aims to elucidate the role of
these cells in AD using a two-fold approach: defining and characterizing these senescent microglia through
proteomic, transcriptomic, and spa�al-omics profiling (Aim 1) and inves�ga�ng whether removing these
senescent microglia can slow or delay AD progression (Aim 2). We plan to leverage a novel transgenic
mouse model to selec�vely ablate newly iden�fied senescent microglia and assess the subsequent impact
on AD progression. If successful, these studies could offer novel insight into AD pathology and iden�fy
poten�al therapeu�c targets by focusing on the selec�ve elimina�on of senescent microglia.
Status | Active |
---|---|
Effective start/end date | 4/15/24 → 3/31/26 |
Funding
- National Institute on Aging: $461,058.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.